ClariVest Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$9.76M	Hold	600,816	–	–	1%	11
2024 Q2	$9.76M	Buy	600,816 +9,816	+2%	+$151K	1%	11
2024 Q1	$8.34M	Buy	591,000 +198,700	+51%	+$2.5M	0.86%	13
2023 Q4	$4.1M	Sell	392,300 -7,600	-2%	-$71K	0.23%	78
2023 Q3	$4.08M	Buy	399,900 +1,400	+0.4%	+$13K	0.22%	79
2023 Q2	$3M	Sell	398,500 -9,600	-2%	-$77.8K	0.15%	97
2023 Q1	$3.61M	Sell	408,100 -7,300	-2%	-$72.2K	0.16%	114
2022 Q4	$3.79M	Sell	415,400 -16,100	-4%	-$140K	0.18%	103
2022 Q3	$3.48M	Buy	431,500 +33,000	+8%	+$292K	0.17%	108
2022 Q2	$3M	Sell	398,500 -12,100	-3%	-$105K	0.13%	136
2022 Q1	$3.86M	Buy	410,600 +313,100	+321%	+$2.61M	0.15%	138
2021 Q4	$782K	Buy	97,500 +9,100	+10%	+$82.1K	0.02%	370
2021 Q3	$861K	Buy	88,400 +1,000	+1%	+$9.36K	0.03%	344
2021 Q2	$865K	Sell	87,400 -4,600	-5%	-$48.7K	0.03%	319
2021 Q1	$1.06M	Sell	92,000 -3,600	-4%	-$41.3K	0.04%	278
2020 Q4	$923K	Sell	95,600 -300	-0.3%	-$2.87K	0.03%	282
2020 Q3	$864K	Buy	95,900 +17,600	+22%	+$186K	0.03%	315
2020 Q2	$966K	Buy	78,300 +26,350	+51%	+$298K	0.03%	326
2020 Q1	$467K	Buy	+51,950	New	+$532K	0.01%	405
2019 Q2	–	Sell	-9,818	Closed	-$154K	–	748
2019 Q1	$154K	Sell	9,818 -300	-3%	-$5.29K	﹤0.01%	526
2018 Q4	$156K	Sell	10,118 -1,482	-13%	-$30.4K	﹤0.01%	569
2018 Q3	$251K	Buy	+11,600	New	+$269K	﹤0.01%	560